Related Experiment Video

Updated: Oct 8, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

[Invasive aspergillosis on a surgical intensive care unit]

P Kujath1, I Klempien, E Muhl

  • 1Klinik für Chirurgie, Universitätsklinikum Lübeck, Germany.

Mycoses
|April 9, 2001
PubMed

Insights

Invasive aspergillosis is a rare but serious fungal infection in surgical intensive care units. Early diagnosis and treatment are crucial for patient outcomes, despite high mortality rates.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Invasive aspergillosis is a severe opportunistic infection.
  • Surgical intensive care units (SICU) present unique challenges for managing invasive fungal infections.

Observation:

  • A retrospective study identified 12 cases of invasive aspergillosis among 4777 patients in a SICU between 1995 and 2000.
  • Patients presented with diverse manifestations, including mediastinitis, aspergilloma, and bronchoalveolar aspergillosis.
  • The study population exhibited a high burden of risk factors for systemic mycoses and significant underlying comorbidities.

Findings:

  • The primary treatment involved amphotericin B, often combined with flucytosine or itraconazole.
  • Amphotericin B aerosol inhalation was used in some cases, and voriconazole was administered for therapeutic failures.
  • A high mortality rate of 83% (10 out of 12 patients) was observed, with 7 deaths attributed to underlying conditions.

Implications:

  • This study highlights the critical nature of invasive aspergillosis in SICU patients.
  • Aggressive antifungal therapy is essential, but outcomes remain poor due to patient comorbidities.
  • Further research into risk stratification and novel therapeutic strategies for invasive aspergillosis in critically ill patients is warranted.

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...